Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_957bcaa32ded75fe81588cf81da08ddb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-51026 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-512 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-51405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-51113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-512 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 |
filingDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c77bc5ad5c3391817d085a2d99ef68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98f3324ba9bbf8794d6915a40655fba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7552524da30cfd282d79d1f1b640a71 |
publicationDate |
2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020392169-A1 |
titleOfInvention |
Acyclic antivirals |
abstract |
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HBV and/or HDV and/or HIV infection with one or more nucleotide analogs. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485753-B2 |
priorityDate |
2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |